Health care stocks were flat to lower pre-bell Wednesday as the iShares Biotechnology ETF (IBB) was unchanged and the Health Care Select Sector SPDR Fund (XLV) was down 0.5% recently.
Medtronic (MDT) shares were up 0.5% after the company reported higher fiscal Q4 non-GAAP earnings and net sales.
Moderna (MRNA) said it has voluntarily withdrawn its Biologics License Application for mRNA-1083, its flu and COVID combination vaccine candidate for adults aged 50 and older. Shares of Moderna were more than 1% higher premarket.
Belite Bio (BLTE) shares were up 0.4% after the company said the US Food and Drug Administration granted breakthrough therapy designation to its Tinlarebant drug for treating Stargardt disease.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.